Victor Chen

🆕 Antifungal TDM toolkit Download the infographics here: funguseducationhub.org/fungal-tdm/

Teaming up with @LAW_OF_ID to promote antimicrobial stewardship! #USAAW23

New C.difficile guidelines for HCT @ASTCT_Journal, #ASTCT Crudos to Carolyn Alonzo and team pubmed.ncbi.nlm.nih.gov/35202891/

Wow, a game changer💥💥 GSK & Vir Submit EUA to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of #COVID19 COMET-TAIL Phase 3 data IM sotrovimab was non-inferior & offered similar efficacy to IV for high-risk populations investors.vir.bio/news-releases/…

🆕🔥🔥🔥Clinical Practice Guideline @IDSAInfo @SHEA_Epi 2021 Focused Update Guidelines on Management of CDI in Adults Major update💥:for patients with an initial CDI episode, guidelines suggest using fidaxomicin rather than a standard course of vancomycin academic.oup.com/cid/advance-ar…

So proud of @PolinaTrachukMD @Vchenidp @Inessags @BronxASP and others from @MontefioreID. Yet more evidence of the value of ID docs and pharmacists. We complete you! @MontefioreNYC @nyulangone

🔥🔥💥Pfizer BioNTech announced positive Topline Results of pivotal #COVID19 vaccine study in adolescents Participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses💥🔥🔥 pfizer.com/news/press-rel…

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA cdc.gov/mmwr/volumes/7… via @CDCgov

💥Excellent Summary💥 @NEJM Results on SARS-CoV-2 Vaccine Trial Efficacy and Viral Neutralization of the B.1.1.7, P.1, and 501Y.V2 Variants, as Compared with Preexisting Variants. With regard to escape from vaccine-induced immunity nejm.org/doi/full/10.10…

Hi #IDtwitter, @UnivHospNewark is actively recruiting for an ID Pharmacist! Feel free to reach out to me with questions. @SIDPharm crew, any bumps are appreciated! 🙌🏿↗️ careers-uhnjcareers.icims.com/jobs/8845/clin…

Injectable HIV therapy! fda.gov/news-events/pr…

With the Jan 7th announcement of the @remap_cap IL-6ra results: medrxiv.org/content/10.110… and last nights @BMJ_Latest RCT drop: bmj.com/content/372/bm… let’s talk about tocilizumab [thread, 1/n]

🔥ACTIV-3 Published 🔥 @NEJM Monoclonal antibody Bamlanivimab "LY-CoV555" , when coadministered with remdesivir, did NOT demonstrate efficacy among hospitalized patients who had #COVID19 without end-organ failure nejm.org/doi/full/10.10…

Its been quite the year. Join @JulieSzymczak, @emilylheil, @zkePharmD, and @ErinMcCreary in our latest #Breakpoints episode for a discussion on stewardship burnout - what is it, who is at risk for it, and what can we do about it? Find this and others at: podcasts.apple.com/us/podcast/bre…

There are currently four new cefepime/BLI combinations in clinical development NEW 🔥fantastic review Update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa #IDTwitter academic.oup.com/jac/advance-ar…

NEW🔥 @antibioticsmdpi @DosingMatters @lodise_tom Use of Oral Tetracyclines "doxycycline, minocycline, and omadacycline" in the Treatment of Adult Patients with CAP: A Literature Review on the Often-Overlooked Antibiotic Class. #IDTwitter @mgh_ast mdpi.com/2079-6382/9/12…

@RealTimeCOVID19 clinical call notes Summary from Jay Butler MD and Amanda Cohn MD after ACIP meeting 1. Separate monoclonal antibody and vaccine, at least 90 days 2. No switching between vaccines 3. Okay in pregnancy, no routine testing for pregnancy

✨✨Fantastic Review✨✨ @antibioticsmdpi ✴️Very important question✴️ Follow-Up Blood Cultures Useful in the Antimicrobial Management of Gram Negative Bacteremia? A Reappraisal of Their Role Based on Current Knowledge #IDTwitter mdpi.com/2079-6382/9/12…

Love those post rotation cupcakes

🔔Breaking news🔔 ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention #IDTwitter HPTN 083 viivhealthcare.com/en-gb/media/pr…